Mark Hamalainen is cofounder of the Longevity Biotech Fellowship. His career has progressed from manual bench work in academia, to lab automation at Synthego, to longevity movement building - always seeking better methods and higher leverage ways to accelerate progress.
The Longevity Biotech Fellowship (LBF)’s mission is to enable a future where everyone can access a healthy, unlimited lifespan. This roadmap includes research, technology, and institutional innovations on the path to that post-aging future. It categorizes efforts into key strategies: Acceleration, Replacement, Bioengineering, Pharmacology, Cryostasis, and Longevity Lifestyle, broken into specific sub-projects, each evaluated for impact and investment efficiency. We highlight underfunded yet critical areas like Replacement and Cryostasis. Future iterations will detail specific projects, costs, and timelines across the whole roadmap. The LBF seeks partnerships and support for this groundbreaking work in extending human lifespans. Apply to the LBF at longbiofellowship.org, or reach out to us with any questions about membership, sponsorship, investment, at [email protected].